Donald Trump’s justice department is investigating claims that Pfizer delayed positive news about its Covid-19 vaccine until ...

Kotak Alternate Asset Managers have announced an investment of ₹1,050 crore in Tirupati Medicare Ltd, a contract development ...

Pfizer's stock is poised for growth due to its strong pipeline, smart cost management, and recovery from COVID-19 revenue ...

Haleon offers plenty of stability amidst the current market volatility, with its Power Brands driving strong organic growth.

Haleon has named Nathalie Gerschtein as president North America, following Lisa Paley’s announcement to step down from her ...

This year’s unexpected demand for European stocks is helping to drive the region’s largest wave of block sales this century, ...

In a report released on March 20, Karel Zoete from Kepler Capital maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price ...

The pharma is spending $2.5 billion on an R&D center in Beijing. Elsewhere, Adaptimmune warned it could run out of cash and Pfizer sold its remaining stake in Haleon.

Pfizer divested 7.3% remaining stake in Haleon, or approximately 662 million shares, to institutional investors and Haleon ...

Pfizer has officially kissed goodbye to its consumer health venture by selling its final 7.3% stake in Haleon for a tidy $3.3 ...

A roundup of the latest health news includes Yemen's malnutrition crisis, potential CDC leadership changes, the role of ...

AstraZeneca signed a deal with Alteogen worth up to $1.35 billion for subcutaneous cancer drugs. Taiho Pharmacetical bought ...